Industry experts say biotechs must prioritize validation, maturity, and alternative financing to overcome a lack of long-term funding.
Funding lifelines: How to cross the 'valley of death'
Related Posts
SALESCORE Raises ¥1.15 Billion in Series B
SALESCORE, a Tokyo, Japan-based company whose vision is to make the joy of achievement a natural part of life, has raised ¥1.15 billion (USD 6.4M) […]
Punto Health Raises $2.7 Million Seed Round
Punto Health, a London, UK-based startup building an AI-driven platform for early detection and personalized support in dementia and cognitive care, has raised $2.7 million […]
AliExpress under scanner for selling childlike sex dolls, France to take legal action against ecommerce site
France has filed legal complaints against AliExpress and Joom for selling childlike sex dolls, calling the platforms a “digital wild west.” Investigators also found weapons […]